Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
1.490
-0.070 (-4.49%)
At close: Sep 26, 2025, 4:00 PM EDT
1.441
-0.049 (-3.29%)
After-hours: Sep 26, 2025, 7:30 PM EDT
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $2.23 million as of September 26, 2025. Its market cap has decreased by -9.95% in one year.
Market Cap
2.23M
Enterprise Value
-2.04M
1-Year Change
-9.95%
Ranking
Category
Stock Price
$1.49
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $2.23M, a decrease of -96.70%. That is a compound annual growth rate of -58.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 2.23M | -17.26% |
| Dec 31, 2024 | 2.69M | 78.03% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
| Nov 10, 2021 | 67.50M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 661.07B |
| Johnson & Johnson | 427.31B |
| AbbVie | 392.16B |
| UnitedHealth Group | 314.86B |
| Novo Nordisk | 259.65B |
| Novartis AG | 238.19B |
| AstraZeneca | 233.83B |
| Abbott Laboratories | 229.90B |